(Please click item to obtain PDF)
Inmedix Research Studies
A Randomized, Double-Blind, Placebo Controlled Trial of Pramipexole, a Dopamine Agonist, in
Patients With Fibromyalgia Receiving Concomitant Medications, Arthritis & Rheumatism, Vol. 52, No. 8, August 2005, pp2495-25-5, Andrew J. Holman, M.D., Robin R. Myers
Preliminary Efficacy of the Dopamine Agonist, Pramipexole, for Fibromyalgia: The First, Open Label,
Multi-center Experience. Journal of Musculoskeletal Pain, Vol 12(1), 2004, Andrew J. Holman, M.D., Richard Neiman, Robert Ettlinger
Ropinirole, Open Preliminary Observations of a Dopamine Refractory Fibromyalgia, Journal of Clinical Rheumatology, Volume 9, Number 4, August 2003 Andrew J. Holman, M.D.
Published Research Articles by Dr. Andrew J. Holman, M.D., Chief Science Officer
Holman AJ, Ng E. Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. Autonomic Neuroscience Basic Clinical 2008 in press.
Holman AJ. An alternative, autonomic rationale for decreased risk of MI in patients with RA responsive to anti-TNF therapy: comment on article by Dixon. Arthritis & Rheumatism 2008 in press.
Holman AJ. Positional cervical spinal cord compression and fibromyalgia: a novel comorbidity with important diagnostic and treatment implications. Journal of Pain 2008 in press: e publication released 5-22-08.
Treatment of Fibromyalgia: a changing of the Guard. Women’s Health (2005) 1(3), 409-420 (Future Medicine), Andrew J. Holman, M.D.
Dopamine. From Parkinson’s Disease to Fibromyalgia. Fibromyalgia Frontiers, 2005. Volume 11, Number 1. Andrew J. Holman, M.D.
Fibromyalgia & Dopamine. FM research enters a brave new world. Fibromyalgia Aware. December 2004 – March 2005. Andrew J. Holman, M.D.
Fibromyalgia and Dopamine Receptors, A new Road Map Toward Progress. Fibromyalgia Frontiers, 2003, Volume 11, Number 3. Andrew J. Holman, M.D.
Other:
article
Fibromyalgia: Not all in your head, Newsweek, May 19, 2003, Anne Underwood.
video
Watch online clips of Fibromyalgia: Show Me Where It Hurts, by Angler Biomedical Technologies.
"a front row seat on some of the cutting edge research and breakthroughs being made to conquer fibromyalgia. . . . . "
